STAAR Surgical Company (STAA) vs Tandem Diabetes Care, Inc. (TNDM)
A side-by-side comparison of STAAR Surgical Company and Tandem Diabetes Care, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
STAA
STAAR Surgical Company
$22.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TNDM
Tandem Diabetes Care, Inc.
$16.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — STAA vs TNDM
growth of $100 · dividends reinvested · last 10ySTAA +144.0% (+9.3%/yr)TNDM -78.8% (-14.4%/yr)STAA compounded faster over this window
Log scale — wide-divergence pair
STAA TNDM
STAA vs TNDM: by the numbers
- •TNDM is the larger company ($1.11B vs $1.10B market cap).
- •STAA is profitable (1.13% net margin) while TNDM runs a net loss (-6.08%).
- •TNDM grew revenue faster over the past five years (11.48% vs 10.49% CAGR).
Metrics side by side
Valuation
| Metric | STAA | TNDM |
|---|---|---|
| P/E ratio | 276.87 | N/A |
| Forward P/E | 76.31 | N/A |
| P/S ratio | 3.25 | 1.06 |
| P/B ratio | 3.02 | 8.49 |
| EV / EBITDA | 22.47 | N/A |
Profitability
| Metric | STAA | TNDM |
|---|---|---|
| Gross margin | 76.23% | 56.01% |
| Operating margin | -19.19% | -4.13% |
| Net margin | 1.13% | -6.08% |
| ROE | 1.05% | -48.56% |
| ROIC | 4.80% | -4.77% |
Growth (annualized)
| Metric | STAA | TNDM |
|---|---|---|
| Revenue CAGR (5Y) | 10.49% | 11.48% |
| Total return CAGR (5Y) | -28.41% | -32.93% |
Frequently asked
- Which has grown faster, STAA or TNDM?
- Over the past five years, TNDM grew revenue faster — STAA at a 10.49% CAGR versus TNDM at 11.48%.
- Is STAA or TNDM more profitable?
- STAA runs the higher net margin — STAA at 1.13% versus TNDM at -6.08%.
- How have STAA and TNDM total returns compared?
- Over the past 10 years, STAA delivered 9.25% and TNDM delivered -14.43% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.